van der Leest, R J T; de Vries, E; Bulliard, J-L; Paoli, J; Peris, K; Stratigos, A J; Trakatelli, M; Maselis, T J E M L; Situm, M; Pallouras, A C; Hercogova, J; Zafirovik, Z; Reusch, M; Olah, J; Bylaite, M; Dittmar, H C; Scerri, L; Correia, O; Medenica, L; Bartenjev, I; Guillen, C; Cozzio, A; Bogomolets, O V; del Marmol, V (2011). The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010. Journal of the European Academy of Dermatology and Venereology, 25(12):1455-1465.
Full text not available from this repository.
Background: Euromelanoma is a skin cancer education and prevention campaign that started in 1999 in Belgium as ‘Melanoma day’. Since 2000, it is active in a large and growing number of European countries under the name Euromelanoma.
Objective: To evaluate results of Euromelanoma in 2009 and 2010 in 20 countries, describing characteristics of screenees, rates of clinically suspicious lesions for skin cancer and detection rates of melanomas.
Methods: Euromelanoma questionnaires were used by 20 countries providing their data in a standardized database (Belgium, Croatia, Cyprus, Czech Republic, FYRO Macedonia, Germany, Greece, Hungary, Italy, Lithuania, Luxembourg, Malta, Moldavia, Portugal, Serbia, Slovenia, Spain, Sweden, Switzerland and Ukraine).
Results: In total, 59 858 subjects were screened in 20 countries. Most screenees were female (64%), median ages were 43 (female) and 46 (male) and 33% had phototype I or II. The suspicion rates ranged from 1.1% to 19.4% for melanoma (average 2.8%), from 0.0% to 10.7% for basal cell carcinoma (average 3.1%) and from 0.0% to 1.8% for squamous cell carcinoma (average 0.4%). The overall positive predictive value of countries where (estimation of) positive predictive value could be determined was 13.0%, melanoma detection rates varied from 0.1% to 1.9%. Dermoscopy was used in 78% of examinations with clinically suspected melanoma; full body skin examination was performed in 72% of the screenees.
Conclusion: Although the population screened during Euromelanoma was relatively young, high rates of clinically suspected melanoma were found. The efficacy of Euromelanoma could be improved by targeting high-risk populations and by better use of dermoscopy and full body skin examination
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic|
|DDC:||610 Medicine & health|
|Deposited On:||15 Mar 2012 09:34|
|Last Modified:||28 Nov 2013 00:24|
|Citations:||Web of Science®. Times Cited: 12|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page